David Esposito

President and Chief Executive Officer

ONL Therapeutics

ONL Therapeutics is a biopharmaceutical company committed to protecting the vision of patients with a range of retinal diseases and conditions. 
 
ONL is the first and only company focused on preventing Fas-mediated death of key retinal cells, which is a root cause of vision loss and a leading cause of blindness.

Allergenis

AllerGenis is revolutionizing the diagnosis and management of food allergies with blood testing based on epitope-mapping technology.
AllerGenis was formed from a collaboration between Genisphere (proprietary amplification technology to increase the sensitivity of diagnostic tests) and Hugh Sampson, M.D., Director of the Jaffe Food Allergy Institute of the Mount Sinai School of Medicine.

Member of the Board of Directors

Hemotek

Hemotek is focused on bringing the benefits of Ox66 to multiple segments in the life science market.  Ox66 is the only solid form of oxygen, designed to be taken orally or applied topically, for its healing and pain relieving properties. Ox66 has the proven potential to provide oxygen to for any insult or injury to the human body resulting in low oxygen levels in cells and tissues.

Harvest Time Partners, Inc.

Harvest Time Partners, Inc. is a personal and professional development company.
We help YOU be your BEST for those you care about most - At Home - At Work - In Your Community
We create products and services to help YOU in the journey to reach your full potential.

Managing Partner

Shield Bio

Shield Bio has developed the Target-X platform, a solution to microbial detection, species identification and antibiotic susceptibility prediction with blazing speed and accuracy.
Shield Bio is building universal sequencing and has made 3rd Gen Sequencing work reliably and accurately in less than 1 minute

Evergreen Mergers & Acquisitions (EMA Partners, LLC)

EMA Partners supports middle market companies in evaluating and executing on key strategic initiatives including: (1) Business strategy transformation (2) Company sales, divestitures, and buy side acquisitions (3) Licensing and intellectual property monetization and (4) Capital raises and recapitalizations

Director

Medizone International (MZEI)

Director - Chairman Of The Board

Armune BioScience, Inc.

Armune BioScience developed and commercialized unique technology leveraging the immune system’s response to several types of cancers. Armune gained the interest of numerous strategic buyers and closed a deal with Exact Sciences in December of 2017 to acquire core assets of the business.

Chief Operating Officer

Thermo Fisher Scientific

Vice President, Commercial Operations US

Phadia AB

President, Phadia US

David is an experienced healthcare CEO and combat veteran.
He has built and scaled multiple healthcare companies that resulted in successful exits.
- CEO:  Armune BioScience (sold to Exact Sciences [EXAS] Dec. 2017).
- US President: Phadia US/AB (sold to Thermo Fisher Scientific [TMO] Sept. 2011)

Thank you to the International Business Times for giving us a chance to tell the story of our work at ONL Therapeutics. We continue to make progress with the Galaxy Clinical Trial for patients with Geographic Atrophy (GA) associated with age-related macular degeneration (AMD). Thank you. https://lnkd.in/exgn3Pe8

Chief Executive Officer at ONL Therapeutics

Frank "Warlord" Hancock - Great job leading the way with getting the book pulled together and capturing the stories from all us.  "Above the Rest" 1/327 INF

Zac - Thanks for having me on the show and giving us a chance to share some experiences on leadership. You have a terrific podcast and asked some very thoughtful questions. Thank you

From leading soldiers on the battlefield to leading teams in biotech innovation — David Esposito has mastered what it means to build with courage, clarity, and purpose.

In our latest conversation, we unpack what real leadership looks like under pressure, how to recover from failure without losing faith, and why purpose must always come before profit.

This episode is a powerful reminder that growth isn’t linear, it’s earned through resilience, integrity, and relentless optimism.

🎥 Watch the full episode now: https://lnkd.in/gAUs7uft

🌐 Connect with David Esposito:
Websites: https://lnkd.in/gxdQWMNd and https://lnkd.in/g3X5qRa2
LinkedIn: https://lnkd.in/gsFmwGVW

🎬 More episodes here: https://lnkd.in/g5dp6QR5

🎧 Audio version coming soon to Apple Podcasts: https://lnkd.in/g9Pr7aDs


If this episode hits home, don’t forget to subscribe and leave a review—it helps more leaders find the conversations that matter.

And stay tuned… the next few episodes dive even deeper into what it takes to grow with purpose, integrity, and momentum!


#LeadershipDevelopment #ExecutiveMindset #Entrepreneurship #BiotechInnovation #ResilientLeadership #PurposeDrivenLeadership #ZacPalmer #PerpetualGrowthPodcast #DavidEsposito #ProfessionalGrowth

We don't need a list of accomplishments or several degrees to be a positive influence on others. Keep it simple and start with listening to open a door to their story and we will be on an effective path.

View company: Harvest Time Partners, Inc.

There is no accomplishment in the business world that can compensate for heartbreak at home. No matter what challenges you face, keep trying to be a positive influence on those you care about most.

Link to purchase “The Pathway to Positive Influence” on Amazon  https://amzn.to/3X2YJuC 
Harvest Time Partners
Certified Veteran Owned Business

taplio

David Esposito's Linkedin Analytics

David Esposito

Performance ScoreDavid Esposito's LinkedIn Performance

David Esposito's Best Posts (last 30 days)

Ready to grow your LinkedIn presence?

taplio

.css-6ytdur{background-image:linear-gradient(284deg, rgba(39, 43, 72, 1) 0%, rgba(33, 47, 183, 1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}David Esposito's Linkedin Analytics

David Esposito

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}David Esposito's LinkedIn Performance

David Esposito's Best Posts .css-1emoo84{font-size:var(--chakra-fontSizes-md);font-weight:400;color:var(--chakra-colors-gray-600);}(last 30 days)

Ready to grow your LinkedIn presence?

David Esposito's Linkedin Analytics

Performance ScoreDavid Esposito's LinkedIn Performance

David Esposito's Best Posts (last 30 days)